Serum phosphatidylethanolamine levels distinguish benign from malignant solitary pulmonary nodules and represent a potential diagnostic biomarker for lung cancer

Johannes F. Fahrmann, Dmitry Grapov, Brian C. Defelice, Sandra Taylor, Kyoungmi Kim, Karen Kelly, William R. Wikoff, Harvey Pass, William N. Rom, Oliver Fiehn, Suzanne Miyamoto

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Serum phosphatidylethanolamine levels distinguish benign from malignant solitary pulmonary nodules and represent a potential diagnostic biomarker for lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences